Waban, MA, United States of America

Joshua Korzenik

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Joshua Korzenik

Introduction

Joshua Korzenik is an accomplished inventor based in Waban, Massachusetts. He has made significant contributions to the field of therapeutic agent delivery, holding two patents that showcase his innovative approaches. His work focuses on enhancing the effectiveness of drug delivery systems, particularly for gastrointestinal applications.

Latest Patents

Korzenik's latest patents include "Articles and methods for administration of therapeutic agents" and "Compositions and related methods for targeted drug delivery." The first patent describes articles and methods designed to deliver therapeutic agents to the colon, utilizing secretion-inducing agents to enhance absorption. This innovative approach aims to improve the efficacy of treatments compared to traditional methods. The second patent involves thermoresponsive hydrogel polymers that facilitate targeted drug delivery, featuring properties such as mechanical strength and biocompatibility. These compositions are designed to undergo sol-to-gel transitions under physiological conditions, optimizing the release of therapeutic agents.

Career Highlights

Throughout his career, Korzenik has worked with prestigious institutions, including the Massachusetts Institute of Technology and Brigham and Women's Hospital. His research has focused on developing advanced drug delivery systems that can significantly improve patient outcomes.

Collaborations

Korzenik has collaborated with notable figures in the field, including Carlo Giovanni Traverso and Robert Samuel Langer. These partnerships have contributed to the advancement of his innovative work in therapeutic delivery systems.

Conclusion

Joshua Korzenik's contributions to the field of drug delivery are noteworthy, with his patents reflecting a commitment to improving therapeutic efficacy. His innovative approaches have the potential to transform how therapeutic agents are administered, ultimately benefiting patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…